Who
Lucy Lu
Director
Company insider
Files Form 4 as: Director, Veru; Chief Financial Officer, Fortress Biotech; President, CEO, Avenue Therapeutics.
In numbers
- Trades disclosed
- 35
- Buys
- 11
- Sells
- 0
- Bought
- $241K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 22 Jun 2012
- Last trade
- 4 May 2026
- Last filed
- 6 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 May 2026filed 6 May 2026 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —104,000 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —104,000 at $0.00 | filing |
| 5 Dec 2025filed 9 Dec 2025 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,000 at $0.00 | filing |
| 1 Oct 2025filed 3 Oct 2025 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 6 May 2025filed 8 May 2025 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 1 Jan 2025filed 3 Jan 2025 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —49,383 at $0.00 | filing |
| 1 Oct 2024filed 2 Oct 2024 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 6 Aug 2024filed 7 Aug 2024 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 1 Jan 2024filed 3 Jan 2024 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —3,333 at $0.00 | filing |
| 2 Oct 2023filed 17 Nov 2023 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 9 May 2023filed 11 May 2023 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 10 Feb 2023filed 14 Feb 2023 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Bought | $10K11,976 at $0.84 | filing |
| 1 Jan 2023filed 4 Jan 2023 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 16 Dec 2022filed 19 Dec 2022 | FBIO Fortress BiotechBiotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 2 Nov 2022filed 4 Nov 2022 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 17 Dec 2021filed 20 Dec 2021 | Avenue TherapeuticsBiotechnology | SEC FORM 4 Code A | —411,616 at $0.00 | filing |
| 3 Nov 2021filed 5 Nov 2021 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 17 Aug 2021filed 19 Aug 2021 | VERU VeruBiotechnology | SEC FORM 4 Bought | $33K4,800 at $6.78 | filing |
| 14 May 2021filed 18 May 2021 | VERU Veruoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 12 Feb 2020filed 13 Feb 2020 | Avenue Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —110,959 at $0.00 | filing |
News
Head to Head Analysis: Fortress Biotech (NASDAQ:FBIO) versus 60 Degrees Pharmaceuticals (NASDAQ:SXTP)FBIO · tickerreport.com · 17 Oct 2026Critical Survey: Fortress Biotech (NASDAQ:FBIO) vs. 60 Degrees Pharmaceuticals (NASDAQ:SXTP)FBIO · tickerreport.com · 11 Oct 2026Eli Lilly and Company (NYSE:LLY) and Fortress Biotech (NASDAQ:FBIO) Critical ReviewFBIO · themarketsdaily.com · 7 Oct 2026
0 headlines in the last 90 days name Lucy Lu; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.